TrialBreast cancer research : BCR2014

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.

Karin Beelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.